Akso Health Group ADR (AHG)vsMcKesson Corporation (MCK)
AHG
Akso Health Group ADR
$1.33
+7.26%
HEALTHCARE · Cap: $1.16B
MCK
McKesson Corporation
$1,105.04
+0.20%
HEALTHCARE · Cap: $124.35B
Smart Verdict
WallStSmart Research — data-driven comparison
McKesson Corporation generates 3027611% more annual revenue ($418.79B vs $13.83M). MCK leads profitability with a 1.1% profit margin vs -135.0%. MCK earns a higher WallStSmart Score of 49/100 (D+).
AHG
Avoid12
out of 100
Grade: F
MCK
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+8.4%
Fair Value
$1.54
Current Price
$1.33
$0.21 discount
Margin of Safety
-54.6%
Fair Value
$616.65
Current Price
$1105.04
$488.39 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Generating 2.9B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -89.4% — below average capital efficiency
Revenue declined 12.9%
Expensive relative to growth rate
Moderate valuation
ROE of 0.0% — below average capital efficiency
1.1% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : MCK
The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap.
Bear Case : AHG
The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.
Bear Case : MCK
The primary concerns for MCK are PEG Ratio, P/E Ratio, Return on Equity. Thin 1.1% margins leave little buffer for downturns.
Key Dynamics to Monitor
AHG profiles as a turnaround stock while MCK is a value play — different risk/reward profiles.
MCK carries more volatility with a beta of 0.28 — expect wider price swings.
MCK is growing revenue faster at 7.6% — sustainability is the question.
MCK generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
MCK scores higher overall (49/100 vs 12/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.
Visit Website →McKesson Corporation
HEALTHCARE · MEDICAL DISTRIBUTION · USA
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?